Prudential Financial »

Aeglea Biotherapeutics shares owned by Prudential Financial

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Prudential Financial from 13F filings

Historical chart of Prudential Financial investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Prudential Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Prudential Financial

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.0M 60k 50.44

More positions owned by Prudential Financial

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Dimensional Etf Trust Us Equity Marke (DFUS)
Microsoft Corporation (MSFT)
Pgim Etf Tr Aaa Clo Etf (PAAA)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Lphabet Cap Stk Cl C (GOOG)
Ishares Tr Iboxx Inv Cp Et (LQD)
Meta Platforms Cl A (META)
Pgim Etf Tr Pgim Ultra Sh B (PULS)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Tesla Motors (TSLA)

View all positions for Prudential Financial

Top funds holding Aeglea Biotherapeutics

FMR
BlackRock
Rtw Investments
Vanguard Group
Fairmount Funds Management
Perceptive Advisors
VR Adviser
Vanguard Capital Management
Driehaus Capital Management
State Street Corporation
Paradigm Biocapital Advisors
Commodore Capital
TCG Crossover Management
Tang Capital Management
Capital Research and Management Company - Division 3

View all funds holding Aeglea Biotherapeutics